BioWorld

June 25, 2008

View Archived Issues

Microbix Brokers Deal for Flu Manufacturing Facility in China

After a year of negotiations, Toronto-based Microbix Biosystems Inc. signed a definitive agreement with the Hunan Provincial Government for the construction of a $200 million flu vaccine manufacturing facility. (BioWorld Today) Read More

Congress Urged to Create Incentives for Antimicrobials

Read More

Averages Can Mask Real Gene Methylation Changes

Read More

NewCo News: ACT's Business Model Aims for Steady Stream of Cancer Drugs

Read More

Sirion's Durezol Wins Approval in Ocular Inflammation, Pain

Read More

RXi Follows Public Listing with $8.7M Private Placement

Read More

Other News To Note

Read More

Clinic Roundup

Read More